Ildong Pharmaceutical Co., Ltd. (KRX:249420)

Market Cap	311.45B
Revenue (ttm)	614.94B
Net Income (ttm)	-4.58B
Shares Out	27.93M
EPS (ttm)	-164.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,671
Average Volume	67,758
Open	11,020
Previous Close	11,020
Day's Range	11,000 - 11,310
52-Week Range	10,560 - 20,500
Beta	0.91
RSI	43.45
Earnings Date	Apr 29, 2025

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 1,033
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 249420

Financial Performance

In 2023, Ildong Pharmaceutical's revenue was 600.76 billion, a decrease of -5.80% compared to the previous year's 637.71 billion. Losses were -78.93 billion, -44.25% less than in 2022.